GlassScriptPhysician profile
Daniel P Gibson
NPI 1952477929
$34,581.54
in general payments reported to CMS, 2019-2025
11 companies · $16K in 2025
The $16K reported for 2025 was more than what 92% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $2,401 · 2021: $5,343 · 2022: $3,124 · 2023: $2,098 · 2024: $5,372 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Travel and Lodging: $1,496 · Food and Beverage: $1,221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,550.00 |
| Travel and Lodging | $1,495.86 |
| Food and Beverage | $1,221.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ischemaview, INC. | $20,987.50 | 2022-2025 | |
| Siemens Medical Solutions USA, INC. | $10,192.71 | 2020-2025 | Magnetom Sola |
| Penumbra, INC. | $1,846.90 | 2019-2023 | Penumbra System, Benchmark |
| Medtronic, INC. | $516.12 | 2021-2025 | Pipeline, Solitaire X, Vantage Anterior Fixation System |
| Microvention, INC. | $426.85 | 2019-2024 | Sofia 6f-131cm Str, Web Aneurysm Embolization System, Eric Retrieval Device |
| Medtronic USA, INC. | $299.31 | 2019-2020 | |
| Medtronic Vascular, INC. | $131.03 | 2019 | |
| Stryker Corporation | $82.12 | 2025 | System 9 Cd Nxt |
| Depuy Synthes Sales INC. | $58.19 | 2022 | |
| Veryan Medical Incorporated | $22.79 | 2022 | |
| Imperative Care, INC | $18.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gibson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.